Literature DB >> 1266946

Cyclodextrin nephrosis in the rat.

D W Frank, J E Gray, R N Weaver.   

Abstract

The renal toxicity of the Schardinger dextrins, alpha and beta-cyclodextrin, is manifested as a series of alterations in the vacuolar organelles of the proximal convoluted tubule. These changes begin as an increase of apical vacuoles and the appearance of giant lysosomes. The giant lysosomes characteristic of cyclodextrin nephrosis are notable because of the prominent acicular microcrystals embedded in the lysosomal matrix. Giant vacuoles devoid of acid phosphatase reaction product are found in advanced lesions. The vacuolar apparatus shows advanced changes prior to manifestation of lesions in mitochondria and other organelles. These observations indicate a role of the vacuologenic apparatus in the nephrotic process. Intracellular concentration of toxin via the lysosomal pathway represents a perversion of the physiologic function of the proximal tubule which ultimately leads to cell death.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1266946      PMCID: PMC2032314     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  11 in total

1.  A histochemical study of swelling and vacuolation of proximal tubular cells in sucrose nephrosis in the rat.

Authors:  D T JANIGAN; A SANTAMARIA
Journal:  Am J Pathol       Date:  1961-08       Impact factor: 4.307

2.  The Schardinger dextrins.

Authors:  D FRENCH
Journal:  Adv Carbohydr Chem       Date:  1957

3.  Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran.

Authors:  A B MAUNSBACH; S C MADDEN; H LATTA
Journal:  Lab Invest       Date:  1962-06       Impact factor: 5.662

4.  Study of the mechanism of renal vacuologenesis induced in the rat by ethylenediaminetetraacetate. Comparison of the cellular activities of calcium and chromium chelates.

Authors:  S L Schwartz; C B Johnson; P D Doolan
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

5.  The ultrastructure of the functioning kidney.

Authors:  L D Griffith; R E Bulger; B F Trump
Journal:  Lab Invest       Date:  1967-02       Impact factor: 5.662

6.  An evaluation of the nephrotoxicity of ethylenediaminetetraacetate and diethylenetriaminepentaacetate in the rat.

Authors:  P D Doolan; S L Schwartz; J R Hayes; J C Mullen; N B Cummings
Journal:  Toxicol Appl Pharmacol       Date:  1967-05       Impact factor: 4.219

7.  Studies on renal tubular morphology and toxicity after large doses of dextran 40 in the rabbit.

Authors:  P Diomi; J L Ericsson; N A Matheson; J R Shearer
Journal:  Lab Invest       Date:  1970-04       Impact factor: 5.662

8.  Lysosomal damage and its possible relationship with mitochondrial lesion in rat kidney under obstructive jaundice.

Authors:  G Emanuelli; G Satta; G Perpignano
Journal:  Clin Chim Acta       Date:  1969-07       Impact factor: 3.786

9.  The effects of chronic oral methyl mercury exposure on the lysosome system of rat kidney. Morphometric and biochemical studies.

Authors:  B A Fowler; H W Brown; G W Lucier; M R Krigman
Journal:  Lab Invest       Date:  1975-03       Impact factor: 5.662

10.  Defective function of renal lysosomes in mice with the Chediak-Higashi syndrome.

Authors:  D J Prieur; W C Davis; G A Padgett
Journal:  Am J Pathol       Date:  1972-05       Impact factor: 4.307

View more
  23 in total

1.  Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation.

Authors:  Patricia V Turner; Cynthia Pekow; Mary Ann Vasbinder; Thea Brabb
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

3.  Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.

Authors:  M E Brewster; M S Hora; J W Simpkins; N Bodor
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

4.  The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.

Authors:  H W Frijlink; J Visser; N R Hefting; R Oosting; D K Meijer; C F Lerk
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

Review 5.  Cyclodextrins: their future in drug formulation and delivery.

Authors:  V J Stella; R A Rajewski
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

6.  The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

Authors:  H W Frijlink; A C Eissens; N R Hefting; K Poelstra; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

7.  Effects of pregnanolone and dehydroepiandrosterone on ethanol intake in rats administered ethanol or saline during adolescence.

Authors:  Olga V Gurkovskaya; Stuart T Leonard; Peter B Lewis; Peter J Winsauer
Journal:  Alcohol Clin Exp Res       Date:  2009-04-21       Impact factor: 3.455

8.  Tumors in rat kidney generated by initiation with trans-4-acetylaminostilbene and several promoting treatments.

Authors:  A Hoffmann; W Romen; H G Neumann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Chemical stabilization of a vasoactive S-nitrosothiol with cyclodextrins without loss of pharmacologic activity.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

10.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.